The aim of this study was to investigate the relationships between FGF23, OPG, and coronary artery calcifications (CAC) in this population and to attempt identification of the most powerful biomarker of CAC: FGF23? The gene discussed is TNFRSF11B; the disease is coronary artery calcification.